department of neurology  
Columbia University Medical Center | Department of Neurology
» close window
Michio Hirano, MD
Professor of Neurology
Neuromuscular Disease


  • MD: Albert Einstein College of Medicine
  • Residency: Neurological Institute of New York, The New York-Presbyterian Hospital at Columbia University Medical Center
  • Fellowship: (Neuromuscular Genetics) Neurological Institute of New York, The New York-Presbyterian Hospital at Columbia University Medical Center
Board Certification:
American Board of Psychiatry and Neurology (Neurology and Neuromuscular Medicine)

Insurance: Aetna, Affinity, Healthplus/Amerigroup, CIGNA, Empire BC/BS, HealthPlus, HIP, Oxford, United Healthcare, 1199, Medicare, Medicaid
*Please verify insurance participation with the physician's office when making an appointment.

» The Merritt Center Laboratory of Molecular Neurogenetics
» ALS and Neuromuscular Disorders
» Department of Neurology

» Recent Publications

Dr. Hirano received his B.A. from Harvard College and M.D. from the Albert Einstein College of Medicine. At the Columbia University Medical Center (CUMC), he did his neurology residency training and a post-doctoral fellowship in neuromuscular genetics under Drs. Salvatore DiMauro and Eric Schon.

Currently, Dr. Hirano serves as Co-Director of the CUMC Muscular Dystrophy Association clinic where he sees patients with myopathies and other neuromuscular disorders. He is Director of the H. Houston Merritt Center for Muscular Dystrophy and Related Diseases. Dr. Hirano is studying mitochondrial disorders, including mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) and CoQ10 deficiencies. He is also studying myopathies caused by mtuations in the FHL1 gene.

He is participating in the clinical trial of idebenone for MELAS patients. Together with Co-Principal Investigators, Drs. Salvatore DiMauro and J.L.P (Seamus) Thompson, Dr. Hirano is co-directing the North American Mitochondrial Disease Consortium (NAMDC). Dr. Hirano serves on the NIH Therapeutic Approaches to Genetic Diseases (TAG) study section, Medical Advisory Committee (MAC) of the Muscular Dystrophy Association, and Scientific Advisory Board of the United Mitochondrial Disease Foundation.

» Diagnostic Services for Mitochondrial Disorders and Metabolic Myopathies

Doctors, Department of Neurology
© 2012 The Neurological Institute of New York • 710 W 168th St, New York, NY 10032
Department of Neurology | Columbia University Medical Center | Last updated: December 4, 2012 | Comments
Neurology Columbia University Medical Center